Warning Letter Roundup: Five Firms Cited for GMPs, Other Issues

Drug GMP Report
A A
The FDA issued a slew of warning letters this month to a wide range of sources, from traditional drugmakers to supplement companies, for GMP violations ranging from insufficient sterility practices to metal embedded in pills.

To View This Article:

Login

Subscribe To Drug GMP Report